3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
14
Lymphoma, Follicular
6
Neoplasm Metastasis
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Hemangioma
3
Neoplasms
2
Urogenital Neoplasms
1
Thymoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Myasthenia Gravis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, T-Cell
1
Leukemia, Lymphoid
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hodgkin Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Prednisolone
×
Clear all
No trials found.